Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of British Columbia

$17,500.00

Characterization of the EchA20 catalyzed ring cleavage during Cholesterol Catabolism in Mycobacterium tuberculosis

EF 2018-19

Résumé
Mycobacterium tuberculosis (Mtb), the bacterium responsible for the fatal lung disease tuberculosis, infects one third of the world’s population and causes over 1.5 million deaths annually. The increasing prevalence of drug-resistant strains intensifies the need for novel and more effective treatments. Targeting physiological traits specific to Mtb are ideal for developing therapies, as it minimizes the possibility of harming beneficial bacteria or human cells. One such trait is the complete degradation of cholesterol into small molecular building-blocks to be utilized in growth and virulence. This is a characteristic unique to only a select few bacterial species. As cholesterol is found in significant quantities within human cells walls, it is crucial for Mtb survival. Interestingly, upon of elimination of EchA20, a protein involved in this degradation pathway, cholesterol becomes toxic to Mtb. The goal of this research will be to elucidate the requirements and mechanics of the reaction performed by this protein. I will use structural and biochemical techniques to determine the speed of reaction, structure, and specifics of target molecule recognition. Specifically, the involved techniques include: purification of EchA20, identification of the kinetic parameters, directed mutagenesis, and X-ray crystallography. This will establish foundational information for further investigation into how this protein can be used as a drug target against Mtb. Overall, this research will provide insight into this enzyme’s mechanism of action, contribute to determining EchA20’s role in the pathogenicity of Mtb, and provide a basis for designing novel therapeutics.
Programme
Master's Award: Canada Graduate Scholarships
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
406445
Name
Chorolovski Jessica M
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Characterization of the EchA20 catalyzed ring cleavage during Cholesterol Catabolism in Mycobacterium tuberculosis
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Cholesterol; Crystallography; Directed Mutagenesis; Echa20 Enzyme; Kinetics; Metabolic Pathways; Metabolite; Mycobacterium Tuberculosis; Novel Theraputics; Pathogenicity
Abstract
Mycobacterium tuberculosis (Mtb), the bacterium responsible for the fatal lung disease tuberculosis, infects one third of the world’s population and causes over 1.5 million deaths annually. The increasing prevalence of drug-resistant strains intensifies the need for novel and more effective treatments. Targeting physiological traits specific to Mtb are ideal for developing therapies, as it minimizes the possibility of harming beneficial bacteria or human cells. One such trait is the complete degradation of cholesterol into small molecular building-blocks to be utilized in growth and virulence. This is a characteristic unique to only a select few bacterial species. As cholesterol is found in significant quantities within human cells walls, it is crucial for Mtb survival. Interestingly, upon of elimination of EchA20, a protein involved in this degradation pathway, cholesterol becomes toxic to Mtb. The goal of this research will be to elucidate the requirements and mechanics of the reaction performed by this protein. I will use structural and biochemical techniques to determine the speed of reaction, structure, and specifics of target molecule recognition. Specifically, the involved techniques include: purification of EchA20, identification of the kinetic parameters, directed mutagenesis, and X-ray crystallography. This will establish foundational information for further investigation into how this protein can be used as a drug target against Mtb. Overall, this research will provide insight into this enzyme’s mechanism of action, contribute to determining EchA20’s role in the pathogenicity of Mtb, and provide a basis for designing novel therapeutics.
Competitiondate
201812
Approvedterm2
1 yr 0 mth
Pinamesdelim
Chorolovski, Jessica M
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~